Previous close | 0.4100 |
Open | 0.4100 |
Bid | 0.0100 |
Ask | 4.6500 |
Strike | 240.00 |
Expiry date | 2024-06-21 |
Day's range | 0.4100 - 0.4100 |
Contract range | N/A |
Volume | |
Open interest | 70 |
Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.
Unveiling the Financial and Strategic Position of Eli Lilly and Co in 2024
Guidance lifts are among the most positive announcements shareholders can hear, injecting confidence in the long-term picture.